Clinical Trials · NCT06282588
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
- Phase
- Phase 2/Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Cancer Research Antwerp
- Enrollment
- 493
- Start date
- Dec 2023
- Locations
- 9 sites, Belgium
- Primary endpoint
- Phase 3: PSMA PET metastasis free survival (ppMFS)